Showing results (471-480 of 666) with videos related to

Sort By:
Pageof 67
Journal of Consulting and Clinical Psychology|December 13, 2006
Change in attachment patterns and reflective function in a randomized control trial of transference-focused psychotherapy for borderline personality disorderKenneth N Levy, Kevin B Meehan, Kristen M Kelly, et al.
Personality Disorders|October 15, 2014
Attachment and mentalization in female patients with comorbid narcissistic and borderline personality disorderDiana Diamond, Kenneth N Levy, John F Clarkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2008
Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023Karen Kelly, Kari Chansky, Laurie E Gaspar, et al.
Nuclear Medicine and Biology|October 16, 2014
Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceuticalV Lopez-Rodriguez, R E Gaspar-Carcamo, M Pedraza-Lopez, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiformeChanghu Chen, Denise Damek, Laurie E Gaspar, et al.
Journal of Personality Disorders|August 1, 2017
Clinical Characteristics of Comorbid Narcissistic Personality Disorder in Patients With Borderline Personality DisorderSusanne Hörz-Sagstetter, Diana Diamond, John F Clarkin, et al.
Vaccine|November 3, 2009
The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120Catarina E Hioe, Maria Luisa Visciano, Rajnish Kumar, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 21, 2016
Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor AntagonistN Levy-Cooperman, G McIntyre, L Bonifacio, et al.
Pageof 67